Fujiyama Power Systems down 4.5% on QIP overhang, ESOP dilution concerns

According to the outcome of the board meeting filed on October 15, 2026 (page 1 of the filing), the Board of Directors of Fujiyama Power Systems Limited approved:

1. Fund-raising via QIP
   The company plans to raise funds "by way of issuance of equity shares of the Company through a Qualified Institutions Placement ("QIP")" in line with the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

   The stated objective, as per page 1, is "with a view to achieving and maintaining the minimum public shareholding requirements of the Company."

2. Creation of a QIP Committee
   To execute the transaction, the board has constituted a "QIP Committee" (page 1–2) empowered to determine "the size, timing, number and price of the issue," identify eligible Qualified Institutional Buyers, approve allocation and allotment, appoint intermediaries and advisers, and handle all related filings and approvals.

3. Shareholder nod via postal ballot
   The company will seek shareholder approval for the QIP through a postal ballot. The filing notes (page 1) that "The postal ballot notice will be circulated to the shareholders in due course, in accordance with applicable laws."

The detailed terms are laid out in Annexure-A (page 3):

• Type of securities: "Equity Shares having a face value of Re. 1/- each".
• Type of issue: "Qualified institutional placement".
• Aggregate amount: "For an aggregate amount of not exceeding Rs. 1,200/- Crore (Rupees One Thousand Two Hundred Crore Only), inclusive of such premium, at such price or prices as may be determined in accordance with applicable law."

Crucially, the filing does not specify the issue price, discount, or exact number of shares for the QIP. Those decisions are left to the QIP Committee and will be set later, subject to regulatory and shareholder approvals.

Alongside the QIP decision, the board also approved an ESOP-related share issue, which added to the market’s focus on dilution.

On page 2, the company states that, on the recommendation of the Nomination and Remuneration Committee, the board approved the issue and allotment of 4,11,587 equity shares of face value Re. 1 each at an exercise price of Rs. 398.39/- each under the "Employee Stock Option Plan 2023 ("ESOP 2023")".

The filing further notes (page 2) that, as a result:

• Issued, subscribed and paid-up share capital increased from Rs 30.69 cr/- ("divided into 30,69,01,762 equity shares of Re. 1/- each")
• To Rs 30.73 cr/- ("divided into 30,73,13,349 equity shares of Re. 1/- each").

Annexure-B (page 4) reiterates that this is an "ESOP Allotment" of 4,11,587 Equity Shares.

Annexure-C (page 5) provides further ESOP details, including:

• Number of shares issued: 4,11,587
• Par value: "Re.1/- each"
• Date of issue: "October 15, 2026"
• Exercise price per share: "Rs. 398.39 per equity shares"
• Premium per share: "Rs. 397.39/-"
• Total issued shares after this issue: 30,73,13,349
• Total issued share capital after this issue: Rs 30.73 cr

The company confirms that all shares allotted on ESOP exercise "shall rank pari passu with the existing shares of the Company" (page 5).

The filing itself is largely procedural and does not contain earnings, margins or guidance. It focuses on capital-raising and ESOP implementation. However, the market reaction suggests investors are looking through to the implications for equity supply and dilution:

• Potentially large QIP size: The board has opened the door to raising up to Rs. 1,200/- Crore via equity. While the exact quantum and pricing are yet to be set, the ceiling is material, and the market often prices in the risk of a sizeable equity overhang once such an enabling resolution is in place.

• Immediate increase in share count from ESOPs: The allotment of 4,11,587 shares at Rs. 398.39 each has already expanded the equity base from 30,69,01,762 shares to 30,73,13,349 shares. Though modest in isolation, it reinforces the theme that more equity is coming into the market.

• No clarity yet on timing or discount: Annexure-A makes clear that the QIP price "may be determined in accordance with applicable law" but does not spell out a floor or range. Until those details emerge, investors often assume the possibility of a discount to prevailing prices, which can weigh on the stock.

Live market commentary has highlighted concerns that such a significant capital-raising plan, even if driven by the need to "achiev[e] and maintain[] the minimum public shareholding requirements" (page 1), could dilute existing shareholders and create a near-term supply overhang. That appears to be the main driver of the 4.5% slide to Rs 399, rather than any change in the company’s operating performance.

For context, it is important to note what this board outcome does not cover:

• There are no revenue, profit, EPS or margin figures in this document.
• There is no guidance on future earnings, capex, or return metrics linked to the proposed fund-raise.
• The filing does not break out any planned use of proceeds beyond the broad objective of meeting minimum public shareholding norms.

That means investors currently have only a partial picture: they know the company wants the flexibility to raise up to Rs 1,200.00 cr via QIP and has already increased its share capital through ESOP exercises, but they do not yet know the final size, pricing, timing or detailed deployment of the funds.

From a market-structure perspective, the reaction looks consistent with a classic "dilution and overhang" trade:

• The QIP enabling resolution signals more equity issuance ahead.
• The ESOP allotment shows the share count is already ticking up.
• With no offsetting earnings data or detailed growth plan in this filing, traders have focused on the supply side of the equation, marking the stock down by 4.5%.

Investors will now watch for the postal ballot notice, the QIP Committee’s eventual pricing decision, and any subsequent disclosures that tie the fund-raise more explicitly to growth projects or balance-sheet objectives. Until those arrive, the board’s October 15 decisions are likely to remain an overhang on Fujiyama Power Systems’ share price.